HealthEquity Reports Second Quarter Ended July 31, 2024 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/29/2026

1. WDAY
2. ESTC
3. MRVL
4. AFRM
5. RBRK
6. S
7. ULTA
8. NVDA
9. GAP
10. DG

Go back to HealthEquity Reports Second Quarter Ended July 31, 2024 Financial Results

HealthEquity, Inc (HQY) PT Raised to $103 at Deutsche Bank

September 4, 2024 12:49 PM EDT

Deutsche Bank analyst George Hill raised the price target on HealthEquity, Inc (NASDAQ: HQY) to $103.00 (from $102.00) while maintaining a Buy rating.

The analyst comments "Solid Q2 Beat On Broad-based Strength: HQY reported another strong quarter with F2Q total revenue of $299.9 million coming in... More

HealthEquity, Inc (HQY) PT Lowered to $100 at BofA Securities

September 4, 2024 5:24 AM EDT

BofA Securities analyst Allen Lutz lowered the price target on HealthEquity, Inc (NASDAQ: HQY) to $100.00 (from $105.00) while maintaining a Buy rating.

The analyst comments "Our Buy thesis for HealthEquity is predicated on faster than market organic growth, supplemented by portfolio M&A, and further enhanced by operating leverage. To date, the biggest driver of... More

HealthEquity, Inc (HQY) PT Raised to $110 at BTIG

September 4, 2024 5:10 AM EDT

BTIG analyst David Larsen raised the price target on HealthEquity, Inc (NASDAQ: HQY) to $110.00 while maintaining a Buy rating.

The analyst comments "On Tuesday, 9/3/24 AMC, HQY reported excellent F2Q:25 results. Total revenue of $299.9M +23% y/y exceeded BTIG / consensus estimates of... More